Literature DB >> 7684204

Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry.

J H van Krieken1.   

Abstract

A 66-year-old man presented with a mass just behind the lower part of the left ear. A biopsy showed a moderately differentiated adenocarcinoma that was prostate-specific antigen (PSA)- and prostate-specific acid phosphatase (PSAP)-positive. This finding suggested a metastasis of a prostatic carcinoma. Extensive clinical and radiographical examination revealed no primary prostatic carcinoma or other metastases and serum levels of PSAP and PSA were not elevated. The reliability of the PSA and PSAP staining was studied in a series of 25 adenocarcinomas of various primary sites in females and in 26 salivary gland tumors in both males and females, because a primary adenocarcinoma of salivary gland seemed another possibility in this case. As expected, there was no immunoreactivity for PSA and PSAP in the adenocarcinomas from females, but 6 of 11 pleomorphic adenomas, 0 of 4 monomorphic adenomas, 1 of 6 mucoepidermoid carcinomas, and 1 of 2 adenocarcinomas not otherwise specified (NOS) of the salivary gland showed at least focal staining of both PSA and PSAP. The conclusion was that the patient had a primary salivary gland adenocarcinoma NOS. In males with PSA- and PSAP-positive adenocarcinoma without signs of primary prostatic carcinoma, a salivary gland origin should be considered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684204     DOI: 10.1097/00000478-199304000-00012

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

1.  Nothing to Spit At.

Authors:  Nafiseh Hashemi; Shahreen Billah; Christian P Conderman; Ibrahim Alava; Emilio P Supsupin; Patricia Chevez-Barrios; Ore-Ofe O Adesina
Journal:  J Neuroophthalmol       Date:  2017-12       Impact factor: 3.042

2.  Elevated serum prostate-specific antigen and pancreatic carcinoma.

Authors:  L R Ranganath; G A Lewis; B T Nobbs; P F Goddard; D C Rangedera
Journal:  Postgrad Med J       Date:  1996-06       Impact factor: 2.401

Review 3.  Functional Histology of Salivary Gland Pleomorphic Adenoma: An Appraisal.

Authors:  Asterios Triantafyllou; Lester D R Thompson; Kenneth O Devaney; Diana Bell; Jennifer L Hunt; Alessandra Rinaldo; Vincent Vander Poorten; Alfio Ferlito
Journal:  Head Neck Pathol       Date:  2014-11-08

4.  Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue.

Authors:  H Yu; E P Diamandis; M Levesque; M Giai; R Roagna; R Ponzone; P Sismondi; M Monne; C M Croce
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 5.  Metastasis of occult prostatic carcinoma to the sphenoid sinus: report of a rare case and a review of the literature.

Authors:  Fredrik Petersson; Tan Sien Hui; David Loke; Thomas Choudary Putti
Journal:  Head Neck Pathol       Date:  2011-11-05

6.  Changes in Serum PSA During Normal Menstrual Cycle.

Authors:  Renu Nagar; Abdulghani A Msalati
Journal:  Indian J Clin Biochem       Date:  2012-09-26

Review 7.  Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.

Authors:  Aaron M Udager; Simion I Chiosea
Journal:  Head Neck Pathol       Date:  2017-03-20

8.  Raised prostate-specific antigen in adenocarcinoma of the colon.

Authors:  M Yamamoto; H Hibi; K Miyake
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

9.  Carcinoma of unknown primary origin.

Authors:  Gauri R Varadhachary
Journal:  Gastrointest Cancer Res       Date:  2007-11

10.  Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.

Authors:  Nobuto Yamamoto; Hirofumi Suyama; Nobuyuki Yamamoto
Journal:  Transl Oncol       Date:  2008-07       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.